AAM
NVO

Azzad Asset Management’s Novo Nordisk NVO Stock Holding History

Azzad Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Buy
98,290
+32,644
+50% +$1.55M 0.37% 96
2025
Q4 		$3.34M Buy
65,646
+479
+0.7% +$24.5K 0.33% 97
2025
Q3 		$3.62M Buy
65,167
+1,153
+2% +$67.5K 0.36% 83
2025
Q2 		$4.42M Buy
64,014
+10,484
+20% +$713K 0.47% 48
2025
Q1 		$3.72M Buy
+53,530
New +$4.42M 0.44% 66
2024
Q4 		– Sell
-41,107
Closed -$4.89M – 264
2024
Q3 		$4.89M Buy
41,107
+14,731
+56% +$1.96M 0.55% 38
2024
Q2 		$3.76M Sell
26,376
-8,792
-25% -$1.17M 0.44% 62
2024
Q1 		$4.52M Buy
35,168
+193
+0.6% +$23K 0.53% 46
2023
Q4 		$3.62M Buy
34,975
+1,163
+3% +$115K 0.46% 63
2023
Q3 		$3.07M Sell
33,812
-244
-0.7% -$21.5K 0.44% 67
2023
Q2 		$2.76M Buy
34,056
+148
+0.4% +$12.1K 0.37% 79
2023
Q1 		$2.7M Sell
33,908
-3,894
-10% -$276K 0.38% 85
2022
Q4 		$2.56M Sell
37,802
-43,186
-53% -$2.53M 0.4% 83
2022
Q3 		$3.29M Sell
80,988
-6,280
-7% -$336K 0.33% 105
2022
Q2 		$3.86M Buy
87,268
+45,128
+107% +$2.5M 0.38% 89
2022
Q1 		$2.34M Buy
42,140
+474
+1% +$24.3K 0.34% 103
2021
Q4 		$2.33M Sell
41,666
-3,532
-8% -$191K 0.31% 123
2021
Q3 		$2.17M Sell
45,198
-10,532
-19% -$509K 0.32% 121
2021
Q2 		$2.33M Buy
55,730
+6,080
+12% +$236K 0.35% 104
2021
Q1 		$1.67M Buy
49,650
+2,752
+6% +$98K 0.28% 149
2020
Q4 		$1.64M Buy
46,898
+1,378
+3% +$47.6K 0.3% 133
2020
Q3 		$1.58M Buy
45,520
+1,942
+4% +$64.7K 0.33% 116
2020
Q2 		$1.43M Sell
43,578
-7,672
-15% -$245K 0.33% 112
2020
Q1 		$1.54M Sell
51,250
-42,578
-45% -$1.27M 0.45% 71
2019
Q4 		$2.88M Sell
93,828
-316
-0.3% -$8.75K 0.34% 101
2019
Q3 		$2.73M Buy
94,144
+41,930
+80% +$1.06M 0.34% 102
2019
Q2 		$1.33M Buy
52,214
+4,736
+10% +$117K 0.37% 100
2019
Q1 		$1.24M Sell
47,478
-23,076
-33% -$567K 0.36% 106
2018
Q4 		$1.63M Sell
70,554
-6,198
-8% -$138K 0.55% 46
2018
Q3 		$1.81M Sell
76,752
-7,428
-9% -$181K 0.48% 52
2018
Q2 		$1.94M Sell
84,180
-4,308
-5% -$102K 0.56% 41
2018
Q1 		$2.18M Buy
88,488
+2,086
+2% +$54.8K 0.66% 29
2017
Q4 		$2.32M Buy
86,402
+1,944
+2% +$49.4K 0.73% 26
2017
Q3 		$2.03M Sell
84,458
-6,900
-8% -$156K 0.68% 27
2017
Q2 		$1.96M Buy
91,358
+5,738
+7% +$116K 0.7% 28
2017
Q1 		$1.47M Buy
85,620
+41,412
+94% +$721K 0.55% 44
2016
Q4 		$793K Sell
44,208
-586
-1% -$10.6K 0.33% 120
2016
Q3 		$932K Buy
44,794
+1,368
+3% +$33.9K 0.38% 101
2016
Q2 		$1.17M Buy
43,426
+7,482
+21% +$205K 0.5% 69
2016
Q1 		$974K Buy
35,944
+6,884
+24% +$184K 0.43% 89
2015
Q4 		$844K Buy
29,060
+502
+2% +$13.9K 0.4% 100
2015
Q3 		$775K Buy
28,558
+2,202
+8% +$62.3K 0.41% 102
2015
Q2 		$722K Buy
26,356
+9,482
+56% +$267K 0.36% 119
2015
Q1 		$450K Buy
16,874
+946
+6% +$21.8K 0.22% 181
2014
Q4 		$337K Sell
15,928
-918
-5% -$20.5K 0.18% 222
2014
Q3 		$401K Buy
16,846
+482
+3% +$11.1K 0.23% 178
2014
Q2 		$378K Buy
16,364
+208
+1% +$4.59K 0.23% 185
2014
Q1 		$369K Sell
16,156
-1,654
-9% -$35.2K 0.24% 181
2013
Q4 		$329K Sell
17,810
-540
-3% -$9.41K 0.24% 174
2013
Q3 		$310K Hold
18,350
– – 0.26% 165
2013
Q2 		$310K Buy
+18,350
New +$305K 0.27% 161

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Azzad Asset Management's NVO Position: Q1 2026 in Review

Azzad Asset Management increased its Novo Nordisk (NVO) stake by 50% in Q1 2026, buying an estimated $1.55M and bringing the position to 98,290 shares worth $3.61M. The position accounts for 0.37% of the portfolio, ranked #96.

Azzad Asset Management first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.89M in Q3 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Azzad Asset Management held 98,290 shares of Novo Nordisk worth $3.61M as of Q1 2026.
  • Azzad Asset Management bought 32,644 Novo Nordisk shares in Q1 2026, an estimated $1.55M.
  • Novo Nordisk made up 0.37% of Azzad Asset Management's portfolio in Q1 2026, its #96 holding.
  • Azzad Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
  • Azzad Asset Management's Novo Nordisk position peaked at $4.89M in Q3 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.